Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

martin_van_trieste

Non-profit generic drug company Civica Rx appoints former Amgen quality chief as new CEO

October 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbot, Amgen, Bayer, civica rx, generic drugs, hospitals

Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen …
Appointment
janssen_latest_logo_on_sign_closer

Janssen’s Stelara shows promise across two dosages in ulcerative colitis

October 9, 2018 Manufacturing and Production, Research and Development Janssen, Stelara, pharma, ulcerative colitis

Janssen’s biologic therapy Stelara (ustekinumab) has shown new efficacy in the treatment of moderate to severe ulcerative colitis in two …
News
celgene_1_02

Celgene’s Otezla impresses at Phase 3 in scalp psoriasis

October 9, 2018 Manufacturing and Production, Research and Development Celgene, pharma, psoriasis

Celgene has unveiled new Phase 3 data for Otezla (apremilast), its inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine …
News
capture

The economics of mental health

October 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, health economics and outcomes research, mental health, pharma

Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done …
Feature
alzheimers_sq

Tech firm Tencent aims for 3-minute Alzheimer’s diagnosis with new partnership

October 8, 2018 Research and Development, Sales and Marketing Alzheimer's, pharma, tencent

Chinese tech firm Tencent has partnered up with London-based healthcare technology firm Medopad in a big to accelerate the diagnosis …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10

As September came to a close and October began the UK was hit hard in the headlines after American firm …
News
ianread

Ian Read steps down as Pfizer CEO

October 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Ian Read, Pfizer, pharma

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
Appointment
boardroom

The value of measuring biotech Board performance

October 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RSA Group, biotech, board, life sciences, opinion, pharma

Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life …
Feature

Roche’s flu drug speeds up recovery in Phase III trial

October 4, 2018 Research and Development Roche, drug, flu, pharma, recovery

Swiss multinational Roche’s flu drug baloxavir marboxil significantly sped up recovery time in comparison with placebo, in people at high …
News
baxter

Baxter partners up with Mayo Clinic for new “centre of exellence” in renal care

October 4, 2018 Research and Development Mayo Clinic, baxter, kidney disease, pharma, renal

American pharma firm Baxter has announced a new partnership with the Mayo Clinic in a bid to establish a “renal …
News

Lilly’s Verzenio gets first-line EU approval for HER2- advanced breast cancer

October 3, 2018 Research and Development, Sales and Marketing Cancer, Eli Lilly, Verzenio, breast cancer, pharma

The European Medicines Agency has confirmed its approval of Eli Lilly’s CDK4/6 inhibitor Verzenio (ademaciclib), it has emerged. The therapy …
News
5204602349_c87b204860_z

FDA cracks down on e-cig maker Juul in surprise inspection

October 3, 2018 Research and Development FDA, e-cig, juul, surprise inspection, us San Francisco

The US FDA have launched a surprise inspection of e-cigarette maker Juul’s corporate headquarters in San Francisco, having seized thousands …
News

Novartis forge deal with Boston Pharmaceuticals in effort against AMR

October 3, 2018 Research and Development AMR, Antibiotics, Boston Pharmaceuticals, Novartis, US

Swiss multinational Novartis have entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel …
News

Memorial Sloan Kettering Chief resigns from MSD board

October 3, 2018 Research and Development MSD, Memorial Sloan Kettering Cancer Center, pharma

Dr Craig Thompson, Chief Executive of Memorial Sloan Kettering Cancer Center (MSKCC), the renowned non-profit treatment and research institution based …
News
4768764591_9e4f7f0eb8_z

Clinical trial halted because of Brexit, UK Government downplays concerns

October 3, 2018 Research and Development UK, brexit, clinical trials, politics, research

A clinical trial looking into the safety and efficacy of the drug dutogliptin has been halted due to uncertainties surrounding …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026